Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

NASDAQ:LGND   3:59:55 PM EDT
129.37
+5.49 (+4.43%)
Other Pre-Announcement

Ligand Reports First Quarter 2021 Financial Results

Published: 05/03/2021 20:07 GMT
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B (LGND) - Ligand Reports First Quarter 2021 Financial Results.
Q1 Adjusted Earnings per Share $1.41.
Q1 Earnings per Share $1.05.
Q1 Revenue $55.2 Million.
Q1 Earnings per Share View $1.13, Revenue View $62.9 Million -- Refinitiv Ibes Data (analyst estimates).
Ligand Pharmaceuticals - Affirms Guidance for 2021 Total Revenue to Be About $291 Million and 2021 Adjusted Earnings per Diluted Share to Be Approximately $6.15.